Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Inovio Pharmaceuticals Inc (INO) vs Jersey Mike's Subs Inc. Class A Common Stock (JMKE) Price & Performance

Inovio Pharmaceuticals IncTrade
Jersey Mike's Subs Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Inovio Pharmaceuticals Inc vs Jersey Mike's Subs Inc. Class A Common Stock — how do they compare? Inovio Pharmaceuticals Inc trades at $0.96 (market cap $103.19M), while Jersey Mike's Subs Inc. Class A Common Stock trades at $16.95 (market cap $5.57B). The key difference: Jersey Mike's Subs Inc. Class A Common Stock is far larger — about 54× Inovio Pharmaceuticals Inc's market cap, and Inovio Pharmaceuticals Inc is more actively traded (8,461,580 versus 1,926,450). Which is the better fit depends on your goals — on Pluang, investors hold Inovio Pharmaceuticals Inc for 43 Days and Jersey Mike's Subs Inc. Class A Common Stock for 0 Days on average.

INOJMKE
Market Cap
$103.19M$5.57B
Volume
8,461,5801,926,450
Sector
HealthConsumer Cyclical
52-Week High
$2.60$24.47
52-Week Low
$0.66$16.09
Typical Hold Time
43 Days0 Days
Enterprise Value
$74.52M$7.44B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals (INO) trades at $0.986, down 10.77% in the last session, with a bearish technical signal from moving averages. The company shows consistent quarterly earnings beats but operates with minimal revenue ($65K in 2025) and significant losses (-$85M net income). Key catalyst is the October 30, 2026 FDA decision on INO-3107 for recurrent respiratory papillomatosis. Analyst consensus remains positive with a $2.75 price target despite negative profitability metrics.

The stock presents high-risk biotech speculation with potential upside dependent on FDA approval. Current valuation metrics (P/S 961.51) reflect speculative optimism rather than fundamentals. Major risks include cash burn (-$21.5M net cash flow), regulatory uncertainty, and competitive pressures. Successful commercialization of INO-3107 is critical for viability.

Jersey Mike's Subs Inc. Class A Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INO
97% Buy3% Sell
Avg holding period · 43 Days
JMKE
100% Buy0% Sell
Avg holding period · 0 Days

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Read more on INO →

About Jersey Mike's Subs Inc. Class A Common Stock

Jersey Mike's Subs Inc. operates and franchises fast-casual submarine sandwich restaurants, with locations in US and Canada and franchise agreements extending to UK and Ireland.

Read more on JMKE →